0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Why Not Radioiodine Therapy for Toxic Nodular Goiter?

JOEL I. HAMBURGER, MD; GEORGE KADIAN, MD; HERBERT W. ROSSIN, MD
Arch Intern Med. 1967;119(1):75-79. doi:10.1001/archinte.1967.00290190123011.
Text Size: A A A
Published online

THE USE of radioiodine as the preferred therapy for toxic nodular goiter (TNG) is still controversial. Many investigators remain opposed to this approach.1-16 Usually radioiodine is used only if the patient refuses surgery or if surgery is contraindicated. Only a few investigators favor radioiodine therapy for TNG.17-21 Silver21 is included among them but even in his extensive paper he dealt mostly with small goiters. The estimated average weight was 53 gm, and only 22 of 282 patients had goiters larger than 110 gm.

Good results have been reported with the use of radioiodine therapy for TNG. Good results were obtained even by those who argue against its use,4,6,7,10-16 and even with large multinodular goiters, including those with tracheal compression.15,16,19

Solitary autonomous hyperfunctioning nodules are excluded from this study. Our approach to the diagnosis and management of this intriguing lesion has been published.22,23 This paper offers experience with patients with large

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 8

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();